Motor effects of amphetamine in rats pretreated with either dizocilpine or phencyclidine

Behavioural Brain Research

Volumn 147, Issue 1-2, 2003, Pages 211-215

  Pešić, Vesna ^a   Janać, Branka ^a   Milanović, Desanka ^a   Tomić, Mirko ^a   Veskov, Rosica ^a   Rakić, Ljubisav ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b SERBIAN ACADEMY OF SCIENCES AND ARTS   (Serbia)

Author keywords

Amphetamine; Dizocilpine; Motor activity; Phencyclidine; Rat

Indexed keywords

AMPHETAMINE; DIZOCILPINE; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOTYPY; XENOBIOTIC METABOLISM;

EID: 0344514733     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(03)00142-6     Document Type: Article

References (25)

1. Cone E.J., Vaupel D.B., Yousefnejad D. Monohydroxy metabolites of phencyclidine (PCP): activities and urinary excretion by rat, dog and mouse. J. Pharm. Pharmacol. 34:1982;197-199.
2. Doherty J.D., Simonović M., So R., Meltzer H.Y. The effect of phencyclidine on dopamine synthesis and metabolism in rat sriatum. Eur. J. Pharmacol. 65:1980;139-149.
3. Gambill J.D., Kornetsky C. Effects of chronic D-amphetamine on social behavior of the rat: implications for an animal model of paranoid schizophrenia. Psychopharmacology. 50:1976;215-223.
4. Hata N., Nishikawa T., Umino A., Takahashi K. Evidence for involvement of N-methyl-D-aspartate receptor in tonic inhibitory control of dopaminergic transmission in rat medial frontal cortex. Neurosci. Lett. 120:1990;101-104.
5. Holsztynska E.J., Domino E.F. Biotransformation is a major mechanism for terminating the action of phencyclidine (PCP) in mice. Pharmacologist. 23:1981;192.
6. Holsztynska E.J., Domino E.F. Biotransformation of phencyclidine. Drug Met. Rev. 16:1985-1986;285-320.
7. 2C/2B receptor antagonists: neurochemical and behavioural studies. Neuropharmacology. 39:2000;2318-2328.
8. Javitt D.C., Zukin M.D. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry. 148:1991;1301-1308.
9. Kim J.S., Kornhuber H.H., Schmid-Burgk W., Holzmueller B. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci. Lett. 20:1980;379-382.
10. Koek W., Woods J.H., Winger G.D. MK-801 a proposed non-competitive antagonist of excitatory amino acid transmission, produces phencyclidine-like behavioural effects in pigeons, rats and rhesus monkeys. J. Pharmacol. Exp. Ther. 245:1988;969-974.
11. Laurenzana E.M., Owens S.M. Brain microsomal metabolism of phencyclidine in male and female rats. Brain Res. 756:1997;256-265.
12. Lin L.Y., Kumagai Y., Cho A.K. Enzymatic and chemical demethylenation of (methylendioxy)amphetamine and (methylendioxy)metamphetamine by rat brain microsomes. Chem. Res. Toxicol. 5:1992;401-406.
13. Milanović D., Milošević J., Kanazir S., Rakić L.J., Ruždijić S. Effect of amphetamine and phencyclidine on DNA-binding activities of serum response and dyad symmetry elements. Neurochem Int. 42:2003;409-417.
14. Ouagazzal A., Nieoullon A., Amalric M. Effects of dopamine D1 and D2 receptor blockade on MK-801-induced hyperlocomotion in rats. Psychopharmacology. 111:1993;427-434.
15. Raiteri M., Cerrito F., Cervoni A.M., Levi G. Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. J. Pharmacol. Exp. Ther. 208:1979;195-202.
16. Seiden L.S., Sabol K.E., Ricaurte G.A. Amphetamine: effects on catecholamine systems and behavior. Brain Res. Bull. 31:1993;305-310.
17. Sharp T., Zetterstrom T., Ljungberg T., Ungerstedt U. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis. Brain Res. 401:1987;322-330.
18. Sonders M.S., Keana J.F.W., Weber E. Phencyclidine and psychotomimetic sigma opiates: recent insights into their biochemical and physiological sites of action. TiNS. 11:1988;37-40.
19. Steinpreis R.E. The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis. Behav. Brain Res. 74:1996;45-55.
20. Steinpreis R.E., Salamone J.D. The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microdialysis and behavioral study. Brain Res. 612:1993;263-270.
21. Sturgeon R.D., Fessler R.G., Meltzer H.Y. Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats. Eur. J. Pharmacol. 59:1979;169-179.
22. 3H -dopamine accumulation by rat brain striatal slices Subst. Alcohol Actions Misuse. 1:1980;351-354.
23. Vickroy T.W., Johnson K.M. Stimulation of synaptosomal tyrosine hydroxylation by phencyclidine in vitro. Eur. J. Pharmacol. 71:1981;463-473.
24. Yan Q.-S., Reith M.E.A., Jobe P.C., Dailey J.W. Dizocilpine (MK-801) increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats. Brain Res. 765:1997;149-158.
25. Zar JH, editor. Biostatistical analysis. 2nd ed. New Jersey: Prentice-Hall; 1984.